ALEXANDRA DIPAOLO: Open Payments
NPI 1932505179 · AURORA, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$554 in 18 payments from 10 companies in 2025. Trend: 2023 $125 · 2024 $336 · 2025 $554
Food & beverage: $455Education: $99
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 5 | $195 |
| Exelixis Inc. | 2 | $96 |
| TerSera Therapeutics LLC | 3 | $69 |
| Genmab U.S., Inc. | 1 | $30 |
| Daiichi Sankyo Inc. | 1 | $30 |
| Merck Sharp & Dohme LLC | 1 | $30 |
| ARRAY BIOPHARMA INC | 2 | $29 |
| Gilead Sciences, Inc. | 1 | $28 |
| SOBI, INC | 1 | $26 |
| Eisai Inc. | 1 | $21 |
Products named: CABOMETYX, Vyloy, Zoladex, Tivdak, Enhertu, KEYTRUDA, BRAFTOVI, Trodelvy.
Industry payments across CO — which companies pay providers there.
